期刊文献+

Single-cell analysis identifies phospholysine phosphohistidine inorganic pyrophosphate phosphatase as a target in ulcerative colitis

下载PDF
导出
摘要 BACKGROUND Ulcerative colitis(UC)is a chronic gastrointestinal disorder characterized by inflammation and ulceration,representing a significant predisposition to colorectal cancer.Recent advances in single-cell RNA sequencing(scRNA-seq)technology offer a promising avenue for dissecting the complex cellular interactions and molecular signatures driving UC pathology.AIM To utilize scRNA-seq technology to dissect the complex cellular interactions and molecular signatures that underlie UC pathology.METHODS In this research,we integrated and analyzed the scRNA-seq data from UC patients.Moreover,we conducted mRNA and protein level assays as well as pathology-related staining tests on clinical patient samples.RESULTS In this study,we identified the sustained upregulation of inflammatory response pathways during UC progression,characterized the features of damaged endothelial cells in colitis.Furthermore,we uncovered the downregulation of phospholysine phosphohistidine inorganic pyrophosphate phosphatase(LHPP)has a negative correlation with signal transducer and activator of transcription 3.Significant downregulation of LHPP in UC patient tissues and plasma suggests that LHPP may serve as a potential therapeutic target for UC.This paper highlights the importance of LHPP as a potential key target in UC and unveils its potential role in inflammation regulation.CONCLUSION The findings suggest that LHPP may serve as a potential therapeutic target for UC,emphasizing its importance as a potential key target in UC and unveiling its role in inflammation regulation.
出处 《World Journal of Gastroenterology》 SCIE CAS 2023年第48期6222-6234,共13页 世界胃肠病学杂志(英文版)
基金 Science and Technology Programme of Traditional Chinese Medicine in Zhejiang Province,No.2023ZF114.
  • 相关文献

参考文献1

二级参考文献22

  • 1Maria Papp,Gary L Norman,Istvan Altorjay,Peter Laszlo Lakatos.Utility of serological markers in inflammatory bowel diseases: Gadget or magic?[J].World Journal of Gastroenterology,2007,13(14):2028-2036. 被引量:24
  • 2Ingrid Ordás,Lars Eckmann,Mark Talamini,Daniel C Baumgart,William J Sandborn.Ulcerative colitis[J]. The Lancet . 2012 (9853)
  • 3Bhavya Voleti,David J. Hammond,Avinash Thirumalai,Alok Agrawal.Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter[J]. Molecular Immunology . 2012 (3-4)
  • 4Heba N. Iskandar,Matthew A. Ciorba.Biomarkers in inflammatory bowel disease: current practices and recent advances[J]. Translational Research . 2012 (4)
  • 5Nitin K. Gupta,Ameet I. Thaker,Navya Kanuri,Terrence E. Riehl,Christopher W. Rowley,William F. Stenson,Matthew A. Ciorba.Serum analysis of tryptophan catabolism pathway: Correlation with Crohn’s disease activity[J]. Inflamm Bowel Dis . 2011 (7)
  • 6Shih‐Kuang S.Hong,Brad E.Maltz,Lori A.Coburn,James C.Slaughter,RupeshChaturvedi,David A.Schwartz,Keith T.Wilson.Increased serum levels of L‐arginine in ulcerative colitis and correlation with disease severity[J]. Inflamm Bowel Dis . 2009 (1)
  • 7J.L. Mendoza,M.T. Abreu.Biological markers in inflammatory bowel disease: Practical consideration for clinicians[J]. Gastroenterologie Clinique et Biologique . 2009
  • 8Krithika Balasubramanian,Sandeep Kumar,Rajeev R. Singh,Uma Sharma,Vineet Ahuja,Govind K. Makharia,Naranamangalam R. Jagannathan.Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study[J]. Magnetic Resonance Imaging . 2009 (1)
  • 9Gert Van Assche,Séverine Vermeire,Paul Rutgeerts.Infliximab therapy for patients with inflammatory bowel disease: 10<ce:hsp sp="0.25"/>years on[J]. European Journal of Pharmacology . 2009
  • 10Chad K. Porter,David R. Tribble,Pablo A. Aliaga,Heather A. Halvorson,Mark S. Riddle.Infectious Gastroenteritis and Risk of Developing Inflammatory Bowel Disease[J]. Gastroenterology . 2008 (3)

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部